Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC6A2 | P23975 | 4/20 | 0.76 |
| ▸ | SLC6A4 | P31645 | 4/20 | 0.76 |
| ▸ | SLC6A3 | Q01959 | 6/20 | 0.62 |
| ▸ | KCNQ3 | O43525 | 1/20 | 0.54 |
| ▸ | KCNQ2 | O43526 | 1/20 | 0.54 |
| ▸ | ATM | Q13315 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15862963 | 1.00 | SLC6A2 (0.76) | SLC6A2SLC6A4SLC6A3KCNQ3KCNQ2 | |
| SCHEMBL10037559 | 1.00 | SLC6A2 (0.76) | SLC6A2SLC6A4SLC6A3KCNQ3KCNQ2 | |
| SCHEMBL29174152 | 0.97 | SLC6A2 (0.81) | SLC6A2SLC6A4SLC6A3KCNQ3KCNQ2 | |
| SCHEMBL12354221 | 0.97 | SLC6A2 (0.81) | SLC6A2SLC6A4SLC6A3KCNQ3KCNQ2 | |
| SCHEMBL17712999 | 0.90 | SLC6A3 (0.66) | SLC6A2SLC6A4SLC6A3ATM | |
| SCHEMBL14405112 | 0.84 | SLC6A3 (0.59) | SLC6A2SLC6A4SLC6A3ATM | |
| SCHEMBL15800131 | 0.83 | MAPT (0.65) | SLC6A2SLC6A4SLC6A3KCNQ3KCNQ2 | |
| SCHEMBL1223719 | 0.81 | HDAC4 (0.61) | SLC6A2SLC6A4SLC6A3ATM | |
| SCHEMBL2504396 | 0.81 | HDAC4 (0.61) | SLC6A2SLC6A4SLC6A3ATM | |
| SCHEMBL29451691 | 0.81 | HDAC4 (0.61) | SLC6A2SLC6A4SLC6A3ATM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8092720-B2 | Polymer-supported metal complex catalyst | NATIONAL UNIVERSITY CORPORATION HOKKAIDO UNIVERSITY (JP) | 2012-01-10 | — | — | US | disclosed |
| US-8092720-B2 | Polymer-supported metal complex catalyst | NATIONAL UNIVERSITY CORPORATION HOKKAIDO UNIVERSITY (JP) | 2012-01-10 | — | — | US | disclosed |
| US-8092720-B2 | Polymer-supported metal complex catalyst | NATIONAL UNIVERSITY CORPORATION HOKKAIDO UNIVERSITY (JP) | 2012-01-10 | — | — | US | disclosed |
| US-20090227743-A1 | POLYMER-SUPPORTED METAL COMPLEX CATALYST | NATIONAL UNIVERSITY CORPORATION HOKKAIDO UNIVERSITY (JP) | 2009-09-10 | — | — | US | disclosed |
| US-20090227743-A1 | POLYMER-SUPPORTED METAL COMPLEX CATALYST | NATIONAL UNIVERSITY CORPORATION HOKKAIDO UNIVERSITY (JP) | 2009-09-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090227743-A1 | POLYMER-SUPPORTED METAL COMPLEX CATALYST | PYM1, ARG1, SCO2 | SLC6A2 3734/4885SLC6A4 4026/4885SLC6A3 3225/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.